Open AccessS780 Outcomes for Patients With IBD and Discontinuation of Biologic Therapy Due to Primary vs SLR and Then Treated With Ustekinumab
Author(s) -
Sean Fine,
Badr F. Al Bawardy,
Jessica C. Petrov
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000776652.64633.58
Subject(s) - medicine , ustekinumab , discontinuation , inflammatory bowel disease , retrospective cohort study , crohn's disease , interquartile range , cohort , surgery , disease , infliximab